Most not too long ago, it has been identified that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds into a wide array of endogenous opioids. Not like most opioid receptors, this receptor acts to be a scavenger and would not activate a 2nd